Threshold Pharmaceuticals
Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors.
Employees
Enterprise value
$164—246m
loading funding rounds…
Frazier Healthcare Partners(exited)
Great Point Partners(exited)
Sutter Hill Ventures(exited)
Sofinnova(exited)
CHL Medical Partners(exited)
Morgenthaler Ventures(exited)
Three Arch Partners(exited)
ProQuest Investments(exited)
Pequot Capital Management(exited)
Merck KGaA(exited)
Federated Hermes(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.